Wockhardt Ltd. (WOCKPHARMA) Share Price Falls 4.84% Today; Stock Turns Top Decliner

Wockhardt Ltd. fell to Rs 1,922.80, down 4.84% today, taking its market capitalisation to Rs 32,834.79 crore and placing it among the session’s notable large-cap decliners.

Wockhardt Share Price came under pressure on 10 August 2026, with the stock falling to Rs 1,922.80, down Rs 97.90 or 4.84% for the day. With market capitalisation at Rs 32,834.79 crore, the move stood out because the stock cleared the qualifying price fall threshold for the Large Cap category in Univest’s event framework, making it a stock that moved meaningfully rather than marginally.

The verified market data shows a clear intraday decline rather than a flat or indecisive session. The stock opened at Rs 2,032.85, rose as high as Rs 2,056.95, and then slipped to an intraday low of Rs 1,910 before trading near that lower band at the time of the event capture. That sequence matters because it indicates the share price decline developed after an initially firmer start, leaving Wockhardt among the top decliner names being watched in Stock Market Today and Share Market Today screens.

What is known from the supplied data is the move itself: Wockhardt Share Price Today weakened sharply, turnover reached Rs 11.51 crore, and total traded volume stood at 13,66,968 shares across exchanges. What the data does not establish is a company-specific catalyst, so Univest’s reading here remains focused on price action, sector context, peer positioning and what investors should monitor next. For readers searching Wockhardt Stock News, Wockhardt Share Price Fall or Wockhardt Share Price Update, today’s event is significant because it crossed the verified threshold for its market-cap bucket and arrived with active volume participation.

Wockhardt Ltd. (WOCKPHARMA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,922.8
Previous Close	Rs 2,020.7
Today's Change	Rs -97.9 (-4.84%)
Day Open	Rs 2,032.85
Day High	Rs 2,056.95
Day Low	Rs 1,910
Current Volume (BSE)	59,871
BSE Traded Volume	59,871
NSE Traded Volume	13,07,097
Combined NSE + BSE Volume	13,66,968
Turnover	Rs 11.51 crore
Market Capitalisation	Rs 32,834.79 crore
Market Cap Category	Large Cap

Wockhardt Ltd. (WOCKPHARMA) traded at Rs 1,922.8. versus the previous close of Rs 2,020.7, a fall of 4.84%. The stock opened at Rs 2,032.85, reached Rs 2,056.95, touched Rs 1,910. Reported volume was 59,871.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 32,834.79 crore

Wockhardt Fundamental Analysis, based strictly on the supplied numbers, is more about scale and comparative valuation context than a full balance-sheet view today. The most important verified fundamental marker is market capitalisation of Rs 32,834.79 crore, which is far above the sector benchmark averages included in the dataset.

From a market size perspective, Wockhardt Share Price is attached to a company with market capitalisation of Rs 32,834.79 crore. That does not by itself indicate quality or direction, but it does show the company sits at a much larger scale than the benchmarked Healthcare universe disclosed here. In the same-sector snapshot, the median market capitalisation is Rs 130.80 crore and the average is Rs 460.68 crore across 202 companies, while the maximum benchmark market cap listed is Rs 3,032.97 crore. On this dataset, Wockhardt is materially larger than the peer and benchmark group presented, which can influence how market participants interpret a single-day share price decline.

Because the supplied financial dataset does not include company-specific P/E Ratio, P/B Ratio, ROE, ROCE, EPS, Book Value, Dividend Yield, leverage or cash-flow figures for Wockhardt, today’s Wockhardt Fundamental Analysis is anchored mainly in relative scale and sector comparison rather than profitability ratios. That still provides context: a 4.84% decline in a company of Rs 32,834.79 crore market cap is different in market impact from a similar percentage move in a much smaller healthcare stock.

For investors following Wockhardt Share Price, the key fundamental takeaway from the verified data is that the stock commands a market value far above the same-sector benchmark set used here. That makes today’s move relevant from a market-structure standpoint even without turning the discussion into a rating or forecast. In Univest’s framework, the next question is whether ownership, sector benchmarks and peers add more perspective to the day’s stock performance.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.63x
Benchmark Average P/E	92.4x
Benchmark P/E Range	3.21x to 3,417.8x
Benchmark Median P/B	1.9x
Benchmark Median ROE	10.71%
Benchmark Median ROCE	13.16%
Company Market Capitalisation	Rs 32,834.79 crore
Benchmark Median Market Cap	Rs 130.8 crore

Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

The Healthcare sector snapshot shows that Wockhardt’s price fall happened within a wide and valuation-diverse peer universe. The benchmark covers 202 companies in the same sector, with large dispersion across P/E, P/B, ROE, ROCE and market capitalisation, which is important when judging where today’s move sits in context.

The supplied sectorSnapshot places the company in the Healthcare sector, with the benchmark scope defined as the same sector and a company count of 202. Within this set, P/E data is available for 157 companies. The median P/E is 26.63, the average is 92.40, the minimum is 3.21 and the maximum is 3,417.80. That range is exceptionally wide, suggesting the sector includes both low-multiple and very richly valued names. For Wockhardt Share Price News readers, that breadth matters because healthcare valuation comparisons are rarely meaningful without looking at the spread, not just the average.

P/B data is available for 201 companies, where the median is 1.90 and the average is 2.74, with a minimum of -22.33 and a maximum of 59.75. ROE is reported for 201 companies, with a median of 10.71 and an average of 14.58. ROCE is also available for 201 companies, with a median of 13.16 and an average of 16.61. On company size, the median market capitalisation is Rs 130.80 crore and the average is Rs 460.68 crore, while the benchmark maximum is Rs 3,032.97 crore.

That final point is especially notable: Wockhardt’s market capitalisation of Rs 32,834.79 crore is far above even the maximum market cap listed in the benchmark company set. So while today’s share price fall puts the stock among market movers, the company is operating at a scale substantially beyond the sector sample shown here. Univest therefore reads today’s move as a large-company event inside a sector where many comparison names are much smaller, making peer interpretation useful but imperfect.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	31.12	0.45	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.35	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.2	8.18	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	63.43	6.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,537.93	33.3	6.87	-2.6	16.92

Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 32,834.79 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The peer dataset shows that Wockhardt is being watched against a group of healthcare names whose market capitalisations are much smaller than its own. The most useful takeaway is not a one-to-one ranking on every metric, but the contrast between Wockhardt’s scale and a peer set where valuation and return ratios vary widely.

The supplied peerSnapshot includes names such as Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye Hospital Ltd., Panacea Biotec Ltd., Sai Parenteral’s Ltd., Solara Active Pharma Sciences Ltd., NGL Fine-Chem Ltd. and Venus Remedies Ltd. Their market capitalisations range from Rs 2,068.61 crore to Rs 3,032.97 crore in the examples shown, far below Wockhardt’s Rs 32,834.79 crore. That alone makes Wockhardt a very different-sized market participant relative to this comparison basket.

Among peers with P/E data, the figures span from 17.81 for Venus Remedies to 176.28 for Sai Parenteral’s, with Dishman Carbogen at 31.12, Kwality Pharmaceuticals at 40.20, Beta Drugs at 63.43, Dr Agarwals Eye Hospital at 33.30 and NGL Fine-Chem at 44.02. P/B ratios also vary materially, from 0.45 for Dishman Carbogen to 8.18 for Kwality Pharmaceuticals. ROE ranges from negative figures such as -2.89 for Dishman Carbogen and -2.60 for Dr Agarwals Eye Hospital to strong positive numbers like 28.21 for Kwality Pharmaceuticals and 27.90 for NGL Fine-Chem.

ROCE dispersion is similarly broad, from -0.26 for Dishman Carbogen to 33.91 for NGL Fine-Chem. Hikal shows ROE of 15.22 and ROCE of 16.15, while Beta Drugs reports ROE of 18.65 and ROCE of 22.17. Panacea Biotec’s ROE is 0 with ROCE of 5.36, and Solara Active Pharma Sciences shows ROE of 17.23 and ROCE of 15.34. For Wockhardt Stock News readers, the peer lesson is clear: the sector comparison set is financially mixed, so today’s Wockhardt Share Price Fall is drawing attention chiefly because of the stock’s scale and session move rather than because peers present a uniform pattern.

Why Investors Are Watching Wockhardt

Investors are watching Wockhardt because the stock recorded a verified 4.

• The stock fell from a previous close of Rs 2,020.70 to Rs 1,922.80, a decline of Rs 97.90.
• It opened at Rs 2,032.85, touched Rs 2,056.95, and later dropped to Rs 1,910, showing clear intraday weakness.
• Total volume stood at 13,66,968 shares, including 13,07,097 on NSE and 59,871 on BSE, with turnover of Rs 11.51 crore.

<

• The company carries a market capitalisation of Rs 32,834.79 crore, which is far above the benchmarked Healthcare sample in the supplied sector data.

What investors may monitor next is whether Wockhardt Share Price continues to trade near the day’s lower zone or stabilises after today’s decline. They may also track how the stock behaves relative to Healthcare peers, whether it remains among top decliner screens, and how future Wockhardt Share News compares with the current market-cap and sector context highlighted by Univest.

About Wockhardt

The supplied data places Wockhardt Ltd. in the Healthcare sector. While the dataset here does not provide a longer company profile, products, segment mix or revenue split, it does establish the market’s sector classification and the comparison universe in which the stock is currently being evaluated.

Based on the available market data, Wockhardt Ltd. is tracked under Healthcare and is represented on the exchanges by the symbol WOCKPHARMA. In the context of this article, that places the company within a sector benchmark that includes 202 same-sector companies and a peer list featuring both pharmaceuticals and hospital-focused businesses. This framing is useful for readers looking for Wockhardt Latest News or Wockhardt Company News because it shows where the market currently groups the stock for comparative analysis.

The strongest verified point about Wockhardt in this dataset is its size. With market capitalisation of Rs 32,834.79 crore, it stands well above the market-cap levels of the benchmark companies cited in the sector and peer snapshots. That means trading moves in Wockhardt Share Price can attract attention not only as a stock-specific event but also as a notable move inside the broader Healthcare basket. Univest therefore treats the stock as an important market tracker within its sector classification, especially on days when it appears among top decliner and market movers screens.

Track Wockhardt Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Readers who want to follow Wockhardt Share Price more closely can use Univest to monitor live share price moves, day high and day low levels, turnover, NSE and BSE volumes, and broader Stock Performance trends. Univest also helps users place daily price action alongside sector benchmarks, peer comparisons, market capitalisation context, 52-week levels when supplied, and shareholding pattern data when available. For those tracking Wockhardt Share Price Today, Wockhardt Stock News or Wockhardt Stock Analysis, the value lies in seeing one-day market moves in a structured format without turning the information into an investment recommendation.

Frequently Asked Questions

Why is Wockhardt Share Price falling today?

Ans. Wockhardt Share Price was down 4.84% at Rs 1,922.80 versus the previous close of Rs 2,020.70. The supplied data confirms the price event and active trading, but it does not establish a company-specific catalyst for today's decline.

What is Wockhardt Share Price Today?

Ans. Wockhardt Share Price Today was Rs 1,922.80 at the captured time on 10 August 2026. That represented a fall of Rs 97.90 from the previous close of Rs 2,020.70, putting the stock among notable healthcare decliners.

How much did Wockhardt stock fall in today's session?

Ans. Wockhardt stock fell by Rs 97.90, or 4.84%, in the session covered by this update. The move is significant because it crossed the exact -1% threshold applicable to its Large Cap category in Univest's event framework.

What were the day's open, high and low for Wockhardt?

Ans. The stock opened at Rs 2,032.85, touched an intraday high of Rs 2,056.95 and later declined to a low of Rs 1,910. Trading near the lower end of that range highlighted intraday weakness during the session.

What does today's volume data show for Wockhardt?

Ans. Total traded volume stood at 13,66,968 shares, with 13,07,097 shares on NSE and 59,871 shares on BSE. Turnover was Rs 11.51 crore, showing that the share price decline came with measurable market participation.

What is Wockhardt's market capitalisation?

Ans. Wockhardt's market capitalisation was Rs 32,834.79 crore in the supplied market data. That places it in the Large Cap category for this event and makes it far larger than the sector benchmark companies listed in the snapshot.

Why is Wockhardt considered a top decliner today?

Ans. Wockhardt is treated as a top decliner because its 4. Under Univest's rules, that makes today's price action a verified downside event.

Which sector does Wockhardt belong to in this dataset?

Ans. The supplied dataset classifies Wockhardt under the Healthcare sector. The benchmark used for comparison covers 202 same-sector companies, giving context to the stock's price move, market capitalisation and position against listed healthcare peers.

How does Wockhardt compare with the supplied peers on size?

Ans. Wockhardt's market capitalisation of Rs 32,834.79 crore is far above the supplied peers, whose market values in this snapshot range from Rs 2,068.61 crore to Rs 3,032.97 crore. That makes Wockhardt a much larger market participant.

What should investors monitor next in Wockhardt stock?

Ans. Investors may watch whether Wockhardt holds near the day's low of Rs 1,910 or stabilises after the fall to Rs 1,922.80. They may also track turnover, exchange-wise volume, and relative movement against Healthcare sector peers.